PHARMA

0.245

(%)

SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS) PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY") PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")

PHARMANIAGA BERHAD

Type Announcement
Subject SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)
Description 
PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY")

PROPOSED CONSOLIDATION OF EVERY 5 EXISTING ORDINARY SHARES IN PHARMANIAGA ("PHARMANIAGA SHARE(S)") OR "SHARE(S)") INTO 1 PHARMANIAGA SHARE ("CONSOLIDATED SHARE(S)") ("PROPOSED SHARE CONSOLIDATION")

We refer to the announcement dated 7 April 2026 in relation to the Proposed Share Consolidation ("Announcement"). Unless otherwise defined, the definitions set out in the Announcement shall apply herein.


On behalf of the Board, Affin Hwang IB wishes to announce that the application in relation to the Proposed Share Consolidation has been submitted to Bursa Malaysia Securities Berhad on 8 April 2026.


This announcement is dated 8 April 2026.



Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 08 Apr 2026
Category General Announcement for PLC
Reference Number GA1-08042026-00057


View original announcement